Literature DB >> 1271155

Pharmacokinetic analysis of the disposition of intravenous theophylline in young children.

P M Loughnan, D S Sitar, R I Ogilvie, A Eisen, Z Fox, A H Neims.   

Abstract

The disposition of a single intravenous dose of theophylline, 3.2 mg/kg, was studied using a high-pressure liquid chromatographic assay in ten asthmatic children one to four years of age. The man plasma theophylline clearance was 0.100 +/- 0.036 l/kg/hr, kel 0.49 +/- 0.30 hr-1, betat1/2 3.38 +/- 1.11 hr, alphat1/2 0.13 +/- 0.09 hr, and V1 0.25 +/- 0.13 1/kg. Plasma theophylline clearance was approximately 40% greater in these children than that reported in adults, mainly due to an increased rate of drug elimination. Large interindividual differences were observed. Analysis of data using either a two- or one-compartment model yielded almost identical dosage regimens designed to rapidly achieve and maintain a chosen plasma theophylline concentration. Calculations based upon mean values of pharmacokinetic constants predict that a maintenance dose rate for aminophylline of 30 mg/kg/day, after a loading dose of 5.6 mg/kg, would rapidly achieve and maintain a mean steady-state plasma concentration of theophylline of 10 mg/1. Potential toxicity of such a regimen has not been excluded, since therapeutic trials (with achievement of steady state) have not yet been conducted.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1271155     DOI: 10.1016/s0022-3476(76)81136-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  41 in total

1.  Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.

Authors:  P M Loughnan; A Greenwald; W W Purton; J V Aranda; G Watters; A H Neims
Journal:  Arch Dis Child       Date:  1977-04       Impact factor: 3.791

2.  An approach to the treatment of asthma.

Authors:  M Mellon; G I Incaudo; S Kahler; R N Hamburger; W L Nyhan
Journal:  West J Med       Date:  1978-05

3.  A mechanistic approach for the scaling of clearance in children.

Authors:  Andrea N Edginton; Walter Schmitt; Barbara Voith; Stefan Willmann
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Computer-aided dosage form design. II. Methods for defining a zero-order sustained-release delivery system of maximum formulating flexibility.

Authors:  T Y Lee; R E Notari
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

5.  Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.

Authors:  Hussain Mulla; Fazal Nabi; Sanjiv Nichani; Graham Lawson; R K Firmin; David R Upton
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 6.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

7.  Cimetidine pharmacokinetics and dosage requirements in children.

Authors:  A Somogyi; M Becker; R Gugler
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

Review 8.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

9.  Pharmacokinetics of theophylline in young children with asthma: comparison of rectal enema and suppositories.

Authors:  P Bolme; P O Edlund; M Eriksson; L Paalzow; B Winbladh
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

10.  Impaired theophylline clearance in patients with cor pulmonale.

Authors:  N Vicuna; J L McNay; T M Ludden; H Schwertner
Journal:  Br J Clin Pharmacol       Date:  1979-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.